Search alternatives:
significantly observed » significantly bolstered (Expand Search), significantly altered (Expand Search), significantly clustered (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly observed » significantly bolstered (Expand Search), significantly altered (Expand Search), significantly clustered (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
-
141
Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”
-
142
Image 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.tif
Published 2025“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”
-
143
-
144
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
145
-
146
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
147
-
148
-
149
-
150
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
151
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
152
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
153
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
154
-
155
-
156
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
157
-
158
-
159
-
160